In January 2026, Darren Rosheski settled an out-of-court claim against the NHS over the death of his partner, Helen Dutton. Dutton's bowel cancer was misdiagnosed as irritable bowel syndrome and haemorrhoids in late 2016. The NHS did not admit liability, and the settlement amount remains undisclosed. Rosheski told The Guardian: "I would rather be poor" — money, he said, cannot compensate for his partner's death after the failed diagnosis (The Guardian).

Dutton was 35, a finance manager and mother of one, when she first saw a GP in late 2016 with back pain, rectal bleeding, and altered bowel habits. The GP diagnosed irritable bowel syndrome (a common digestive disorder) and haemorrhoids, and did not recommend further investigation. Two years passed before Dutton returned to the surgery, saw a different doctor, and was referred to Tameside hospital in Greater Manchester. A consultant there found a large lump in her colon and described it as "very sinister," prompting urgent investigation.

In January 2019, a colonoscopy at Tameside confirmed bowel cancer that had already begun to spread. Three weeks later, doctors at Manchester's Christie cancer hospital diagnosed stage 4 advanced rectal cancer — meaning the disease had reached its most serious stage, spreading to other parts of the body. Dutton underwent chemotherapy, radiotherapy, and surgery. She was given the all-clear in June 2020. The cancer returned in August 2020. She died in August 2021, aged 40.

Rosheski and their daughter were financially dependent on Dutton at the time of her death. Rosheski has since been diagnosed with PTSD and complex grief and has worked for only one month since she died. He hired Irwin Mitchell solicitors to pursue the claim.

The wider picture is concerning. NHS England paid out almost £190 million over five years to settle 870 claims involving misdiagnosis or delayed diagnosis of cancer. Total costs including legal fees for those claims rose from £32 million in 2020/21 to £41.3 million in 2024/25 (The Guardian). Olivia Boschat, a solicitor at Bolt Burdon Kemp, described the figures as "really alarming."

The two-year gap between Dutton's initial visit and her referral sits at the centre of this case. The original GP attributed symptoms consistent with colorectal cancer — rectal bleeding, altered bowel habits, back pain — to benign (non-cancerous) conditions without arranging further investigation. When a different GP eventually referred her, the cancer had already metastasised, meaning it had spread from its original site to other organs. That delay is the substance of the claim Rosheski brought, even though the NHS chose to settle without conceding fault.

The rising cost trajectory of cancer misdiagnosis claims matters for several reasons. The 29% increase in total costs between 2020/21 and 2024/25 outpaces general NHS inflation pressures, suggesting either more claims, higher-value settlements, or escalating legal costs per case — or some combination of all three. Each settled claim without an admission of liability leaves the clinical and operational lessons opaque to public scrutiny. Families receive compensation, but the systemic conditions that produced the error remain unexamined outside the litigation itself.

The broader context here is that Rosheski's framing — that he would rather be poor than have lost his partner — cuts against the logic of the tort system, which is the legal framework that monetises loss to achieve closure. His PTSD diagnosis and near-total withdrawal from work illustrate the limits of that framework. The settlement addresses financial dependency for him and his daughter, but the emotional and psychological wreckage extends well beyond what any payout can reach.

For clinical practitioners, the case reinforces a familiar tension in primary care. Symptoms like rectal bleeding and altered bowel habits in a patient under 50 sit at the boundary between common, benign conditions and rare but lethal ones. Current NICE (National Institute for Health and Care Excellence) referral guidance for suspected colorectal cancer uses age thresholds and symptom combinations to trigger "two-week-wait" referrals — an urgent pathway designed to speed up diagnosis. Dutton was 35 when she first presented, below the age brackets that typically escalate urgency under those pathways. Her case raises the question of whether the threshold for referral, rather than the threshold for diagnosis, is where the system failed.

That question remains unresolved. The NHS settled without admitting liability, and no findings of clinical negligence were entered on the public record.